Developments in virus-like particle-based vaccines for HIV

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Virus-like particles (VLPs) hold great promise for the development of effective and affordable vaccines. VLPs, indeed, are suitable for presentation and efficient delivery to antigen-presenting cells of linear as well as conformational antigens. This will ultimately result in a crosspresentation with both MHC class I and II molecules to prime CD4+ T-helper and CD8+ cytotoxic T cells. This review describes an update on the development and use of VLPs as vaccine approaches for HIV.

Original languageEnglish
Pages (from-to)119-127
Number of pages9
JournalExpert Review of Vaccines
Volume12
Issue number2
DOIs
Publication statusPublished - Feb 2013

Fingerprint

Virus-Like Particle Vaccines
Virion
HIV
Antigen-Presenting Cells
Vaccines
T-Lymphocytes
Antigens

Keywords

  • baculovirus expression vector system
  • broadly neutralizing antibody
  • conformational antigen presentation
  • HIV-VLPs
  • insect cells stable expression
  • vaccines

ASJC Scopus subject areas

  • Immunology
  • Drug Discovery
  • Pharmacology
  • Molecular Medicine

Cite this

Developments in virus-like particle-based vaccines for HIV. / Buonaguro, Luigi; Tagliamonte, Maria; Visciano, Maria Luisa; Tornesello, Maria Lina; Buonaguro, Franco M.

In: Expert Review of Vaccines, Vol. 12, No. 2, 02.2013, p. 119-127.

Research output: Contribution to journalArticle

@article{4c82fda5a59546a99427ecc6febe1a9b,
title = "Developments in virus-like particle-based vaccines for HIV",
abstract = "Virus-like particles (VLPs) hold great promise for the development of effective and affordable vaccines. VLPs, indeed, are suitable for presentation and efficient delivery to antigen-presenting cells of linear as well as conformational antigens. This will ultimately result in a crosspresentation with both MHC class I and II molecules to prime CD4+ T-helper and CD8+ cytotoxic T cells. This review describes an update on the development and use of VLPs as vaccine approaches for HIV.",
keywords = "baculovirus expression vector system, broadly neutralizing antibody, conformational antigen presentation, HIV-VLPs, insect cells stable expression, vaccines",
author = "Luigi Buonaguro and Maria Tagliamonte and Visciano, {Maria Luisa} and Tornesello, {Maria Lina} and Buonaguro, {Franco M.}",
year = "2013",
month = "2",
doi = "10.1586/erv.12.152",
language = "English",
volume = "12",
pages = "119--127",
journal = "Expert Review of Vaccines",
issn = "1476-0584",
publisher = "Expert Reviews Ltd.",
number = "2",

}

TY - JOUR

T1 - Developments in virus-like particle-based vaccines for HIV

AU - Buonaguro, Luigi

AU - Tagliamonte, Maria

AU - Visciano, Maria Luisa

AU - Tornesello, Maria Lina

AU - Buonaguro, Franco M.

PY - 2013/2

Y1 - 2013/2

N2 - Virus-like particles (VLPs) hold great promise for the development of effective and affordable vaccines. VLPs, indeed, are suitable for presentation and efficient delivery to antigen-presenting cells of linear as well as conformational antigens. This will ultimately result in a crosspresentation with both MHC class I and II molecules to prime CD4+ T-helper and CD8+ cytotoxic T cells. This review describes an update on the development and use of VLPs as vaccine approaches for HIV.

AB - Virus-like particles (VLPs) hold great promise for the development of effective and affordable vaccines. VLPs, indeed, are suitable for presentation and efficient delivery to antigen-presenting cells of linear as well as conformational antigens. This will ultimately result in a crosspresentation with both MHC class I and II molecules to prime CD4+ T-helper and CD8+ cytotoxic T cells. This review describes an update on the development and use of VLPs as vaccine approaches for HIV.

KW - baculovirus expression vector system

KW - broadly neutralizing antibody

KW - conformational antigen presentation

KW - HIV-VLPs

KW - insect cells stable expression

KW - vaccines

UR - http://www.scopus.com/inward/record.url?scp=84874047611&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84874047611&partnerID=8YFLogxK

U2 - 10.1586/erv.12.152

DO - 10.1586/erv.12.152

M3 - Article

C2 - 23414404

AN - SCOPUS:84874047611

VL - 12

SP - 119

EP - 127

JO - Expert Review of Vaccines

JF - Expert Review of Vaccines

SN - 1476-0584

IS - 2

ER -